AmerisourceBergen Corporation (ABC) EPS Estimated At $1.81

April 17, 2018 - By Adrian Mccoy

AmerisourceBergen Corporation (NYSE:ABC) Logo

Analysts expect AmerisourceBergen Corporation (NYSE:ABC) to report $1.81 EPS on May, 3.They anticipate $0.04 EPS change or 2.26 % from last quarter’s $1.77 EPS. ABC’s profit would be $397.61M giving it 12.57 P/E if the $1.81 EPS is correct. After having $1.55 EPS previously, AmerisourceBergen Corporation’s analysts see 16.77 % EPS growth. The stock increased 2.56% or $2.27 during the last trading session, reaching $91.04. About 2.81 million shares traded or 32.55% up from the average. AmerisourceBergen Corporation (NYSE:ABC) has declined 3.97% since April 18, 2017 and is downtrending. It has underperformed by 15.52% the S&P500.

AmerisourceBergen Corporation (NYSE:ABC) Ratings Coverage

Among 13 analysts covering AmerisourceBergen Corporation (NYSE:ABC), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. AmerisourceBergen Corporation had 25 analyst reports since October 24, 2017 according to SRatingsIntel. As per Tuesday, March 27, the company rating was maintained by Barclays Capital. On Friday, November 3 the stock rating was maintained by Needham with “Buy”. Needham maintained it with “Buy” rating and $88 target in Wednesday, November 22 report. The company was maintained on Tuesday, February 6 by Mizuho. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, February 6. As per Tuesday, October 24, the company rating was maintained by Mizuho. The firm has “Hold” rating by Mizuho given on Wednesday, January 24. The rating was maintained by Robert W. Baird on Wednesday, January 17 with “Buy”. The rating was maintained by Jefferies with “Hold” on Friday, October 27. The stock of AmerisourceBergen Corporation (NYSE:ABC) has “Buy” rating given on Wednesday, February 7 by Credit Suisse.

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. The company has market cap of $20.00 billion. The Company’s Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It has a 20.6 P/E ratio. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers.

AmerisourceBergen Corporation (NYSE:ABC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.